Kivu Bioscience
Biotech • Antibody-drug conjugates
Kivu Bioscience is a biotech company developing next-generation antibody-drug conjugates for cancer treatment.
Tessellate BIO
Precision oncology medicines • DNA damage response
Tessellate BIO is a preclinical stage biotechnology company that develops precision oncology medicines targeting the DNA damage response and cancers relying on Alternative Lengthening of Telomeres (ALT).